Biogen CEO to step down as the drugmaker plans further Aduhelm cost cuts
Finance

Biogen CEO to step down as the drugmaker plans further Aduhelm cost cuts

admin-dominor

[ad_1]

Biogen's Chief Executive Officer Michel Vounatsos is stepping down as it is grappling with Medicare restricting coverage for its Alzheimer's drug Aduhelm.

[ad_2]

Source link

You May Also Like

Buy the dip in Alibaba? Here’s what the analysts say, after the stock tanked

Buy the dip in Alibaba? Here’s what the analysts say, after the stock tanked

admin-dominor
Elon Musk faces a long legal war with Twitter, which has the upper hand

Elon Musk faces a long legal war with Twitter, which has the upper hand

admin-dominor

Astroworld disaster recalls 1979 Who concert in Cincinnati, other tragedies

admin-dominor

Leave a Reply

Your email address will not be published. Required fields are marked *